Notice2025-10622
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 11, 2025
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 111 (Wednesday, June 11, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 111 (Wednesday, June 11, 2025)]
[Notices]
[Pages 24625-24627]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-10622]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-1268]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Drug Overdose Surveillance and Epidemiology
(DOSE)'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on November
7, 2024, to obtain comments from the public and affected agencies. CDC
did not receive comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
[[Page 24626]]
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No.
0920-1268, Exp. 09/30/25)--Revision--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2022, a total of 107,941 drug overdose deaths occurred,
corresponding to an age-adjusted rate of 32.6 per 100,000 population,
quadruple from the 2002 rate (8.2). From 2021 to 2022, the synthetic
opioid-involved death rate other than methadone increased 4.1%, from
21.8 to 22.7 per 100,000. The psychostimulant-involved age-adjusted
death rate increased more than 34 times, from 0.3 in 2002 to 10.4 in
2022. Two states had a significant increase in non-fatal overdoses
between 2023 and 2024 (DOSE dashboard). In response to the growing
severity of the opioid overdose epidemic, the US government declared
the opioid overdose epidemic a public health emergency on October 26,
2017. The opioid overdose epidemic is one of the U.S. Department of
Health and Human Services (HHS) top priorities. In 2021, HHS expanded
their Overdose Prevention Strategy to focus on four strategic
priorities: primary prevention, harm reduction, evidence-based
treatment, and recovery support.
DOSE 2.0 is a critical element in the support of research and
surveillance to collect more timely and more specific data through
accelerating the speed at which CDC reports drug overdose data. DOSE
2.0 data collection integrates, expands, and enhances previous data
sharing efforts with public health departments initiated under ESOOS
and DOSE 1.0. The goal of DOSE 2.0 is to conduct surveillance of
approximately 80% of all ED facilities in a given jurisdiction for drug
overdoses through the end of the OD2A-S cooperative agreement in 2028.
In 2023, OD2A-S provided funding for 90 jurisdictions: 49 states and
the District of Columbia share data with DOSE 2.0. Though we had hoped
to capture data from all 50 states and the District of Columbia, only
49 states and the District of Columbia applied for this funding
announcement.
Drug Overdose Surveillance and Epidemiology (DOSE) system will
leverage ED syndromic data, as well as line-level emergency department
(ED) and inpatient hospitalization discharge data on ED visits already
routinely collected by state health departments and the District of
Columbia health department. No new data will be systematically
collected from EDs, and health departments will be reimbursed by CDC
for the burden related to sharing ED data with CDC. DOSE system funds
50 health departments (49 state health departments and the health
department of the District of Columbia; ND is the only state not funded
of the 50 states). For DOSE Syndromic Surveillance (SyS) data, 48
health departments (OK and CA do not participate in SyS) will rapidly
share existing ED data with CDC monthly.
Funding for DOSE 2.0 was awarded in September 2023 and we are
requesting an additional three years of data collection to match the
OD2A-S NOFO funding period. Revisions are requested to revise the
number of eligible states, change the data collection template and
revise burden. Based on current data sharing from states we have
decreased our burden estimate to 655 from 975 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments Rapid ED overdose data 45 12 30/60
sharing aggregate data from NSSP form.
BioSense.
Participating health departments Rapid ED overdose data 3 12 3
sharing aggregate data from local form.
syndromic data file.
Participating health department ED and hospitalization 32 1 3
sharing finalized ED and inpatient discharge overdose data
hospitalization aggregate data on form.
total ED/inpatient hospitalization
visits, and metadata on a yearly
basis.
Participating health department Inpatient 3 1 2
sharing finalized aggregate data on hospitalization
total inpatient hospitalization discharge overdose data
visits, and metadata on a yearly form.
basis.
[[Page 24627]]
Participating health department Inpatient 35 1 5
sharing line-level ED/inpatient hospitalization
hospitalization discharge data (.csv) discharge overdose data
on drug overdose-related visits form.
(i.e., any visit with an ICD-10-CM
code between T36-T50, including all
intents, encounters, underdosing, and
adverse effects..
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2025-10622 Filed 6-10-25; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on June 11, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.